You have read all your free articles, to continue reading subscribe to read the rest of this content.
Vakona has signed an agreement with French company GTP Tech to initiate the first manufacturing steps of its acne medicine. GTP Tech, a GTP Bioways company, will develop the industrial process to move on from the preclinical phase towards the manufacturing of antibiotic-free treatment for clinicsAlready a subscriber Login You…
The company is conducting a directed new issue of shares, which is expected to add close to SEK 5.3 million to NeuroVive. Proceeds from the new share issue will be used primarily for continued clinical development of KL1333 and NeuroSTAT. NeuroVive's Board of Directors has decided to conductAlready a subscriber Login You…
Swedish drug development company Modus Therapeutics has had a busy year, and 2019 could take them one step closer to having sevuparin on the market. In 2016 the clinical-stage drug development and Karolinska Development portfolio company Dilaforette Holding changed its name to Modus Therapeutics Already a subscriber Login You have…
The Chinese patent office, the State Intellectual Property Office, has formally approved the company's patent application for IL1RAP as target molecule for antibody therapy of several types of solid tumours. Cantargia is developing antibodies against IL1RAP for treatment of life-threatening diseaAlready a subscriber Login You have read all your free…
